KINNATE BIOPHARMA INC filings

All
Holdings
Significant ownership
Insider transactions
Annual reports
Quarterly reports
Events
Shareholder votes
SEC filings by KINNATE BIOPHARMA INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13D/A2024-04-05Foresite Capital Fund V, L.P.Kinnate Biopharma Inc.00.0%EDGAR
SC 13D/A2024-02-22Foresite Capital Fund V, L.P.Kinnate Biopharma Inc.9,671,64320.5%EDGAR
SC 13D/A2024-02-21ORBIMED ADVISORS LLCKinnate Biopharma Inc.7,559,72916.1%EDGAR
SC 13G/A2024-02-14Lynx1 Capital Management LPKinnate Biopharma Inc.1,997,0064.2%EDGAR
SC 13G/A2024-02-14Nextech V Oncology S.C.S., SICAV-SIFKinnate Biopharma Inc.00.0%EDGAR
SC 13G/A2024-02-14TANG CAPITAL PARTNERS LPKinnate Biopharma Inc.2,601,6475.5%EDGAR
SC 13G2023-11-27TANG CAPITAL PARTNERS LPKinnate Biopharma Inc.2,965,7156.3%EDGAR
SC 13D/A2023-11-17ORBIMED ADVISORS LLCKinnate Biopharma Inc.7,559,72916.0%EDGAR
SC 13D/A2023-11-17Foresite Capital Fund V, L.P.Kinnate Biopharma Inc.9,671,64320.5%EDGAR
SC 13D/A2023-11-14ORBIMED ADVISORS LLCKinnate Biopharma Inc.7,559,72916.0%EDGAR
SC 13D/A2023-11-14Foresite Capital Fund V, L.P.Kinnate Biopharma Inc.9,671,64320.5%EDGAR
SC 13G/A2023-08-14RA CAPITAL MANAGEMENT, L.P.Kinnate Biopharma Inc.00.0%EDGAR
SC 13D/A2023-05-10Foresite Capital Fund IV, L.P.Kinnate Biopharma Inc.9,671,64320.8%EDGAR
SC 13D/A2023-05-08ORBIMED ADVISORS LLCKinnate Biopharma Inc.7,559,72916.2%EDGAR
SC 13D/A2023-05-03ORBIMED ADVISORS LLCKinnate Biopharma Inc.6,098,79713.1%EDGAR
SC 13G/A2023-04-06BlackRock Inc.Kinnate Biopharma Inc.2,277,1094.9%EDGAR
SC 13D/A2023-02-23ORBIMED ADVISORS LLCKinnate Biopharma Inc.4,693,62910.6%EDGAR
SC 13D/A2023-02-22Foresite Capital Fund IV, L.P.Kinnate Biopharma Inc.9,671,64320.8%EDGAR
SC 13G/A2023-02-14Nextech V Oncology S.C.S., SICAV-SIFKinnate Biopharma Inc.2,329,4805.3%EDGAR
SC 13G/A2023-02-14RA CAPITAL MANAGEMENT, L.P.Kinnate Biopharma Inc.4,264,1449.7%EDGAR
External links